ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 153 filers reported holding ANI PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 9.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,321,000 | -54.3% | 21,418 | -46.0% | 0.08% | -44.5% |
| Q3 2019 | $2,891,000 | -25.9% | 39,668 | -16.4% | 0.14% | -21.3% |
| Q2 2019 | $3,902,000 | +15.8% | 47,468 | -0.6% | 0.17% | +33.8% |
| Q1 2019 | $3,370,000 | +58.7% | 47,768 | +1.3% | 0.13% | +51.2% |
| Q4 2018 | $2,123,000 | -5.1% | 47,153 | +19.2% | 0.09% | +30.3% |
| Q3 2018 | $2,237,000 | -12.0% | 39,558 | +3.9% | 0.07% | -15.4% |
| Q2 2018 | $2,543,000 | +133.3% | 38,075 | +103.4% | 0.08% | +122.9% |
| Q1 2018 | $1,090,000 | -25.1% | 18,720 | -17.1% | 0.04% | -20.5% |
| Q4 2017 | $1,455,000 | +22.8% | 22,570 | 0.0% | 0.04% | +18.9% |
| Q3 2017 | $1,185,000 | +27.7% | 22,570 | +13.8% | 0.04% | +48.0% |
| Q2 2017 | $928,000 | +8.0% | 19,825 | +14.2% | 0.02% | 0.0% |
| Q1 2017 | $859,000 | -14.1% | 17,360 | +5.2% | 0.02% | -7.4% |
| Q4 2016 | $1,000,000 | +23.6% | 16,500 | +35.2% | 0.03% | +22.7% |
| Q3 2016 | $809,000 | – | 12,200 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 367,754 | $10,911,000 | 4.08% |
| AIGH Capital Management LLC | 244,500 | $7,254,000 | 1.91% |
| Parkman Healthcare Partners LLC | 108,559 | $3,221,000 | 1.19% |
| Worth Venture Partners, LLC | 60,831 | $1,927,000 | 1.13% |
| Global Alpha Capital Management Ltd. | 323,731 | $9,605,000 | 1.04% |
| Mesirow Financial Investment Management, Inc. | 6,892 | $204,000 | 0.99% |
| MARATHON CAPITAL MANAGEMENT | 74,460 | $2,209,000 | 0.71% |
| EMERALD ADVISERS, LLC | 455,880 | $13,526,000 | 0.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 356,865 | $10,588,000 | 0.61% |
| Jackson Creek Investment Advisors LLC | 32,698 | $1,120,000 | 0.45% |